GlassScriptPhysician profile
Richard K Johnson
NPI 1669494175
$256.14
in general payments reported to CMS, 2019-2025
10 companies · $39.78 in 2025
The $39.78 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.41 · 2022: $27.17 · 2023: $92.78 · 2024: $58.00 · 2025: $39.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $69.98 | 2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $35.77 | 2024-2025 | Stratafix, Surgicel Nu-Knit, Monocryl |
| Organogenesis INC. | $28.16 | 2024 | |
| Innocoll Pharmaceuticals Limited | $27.17 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.80 | 2023 | Andexxa |
| Davol INC. | $19.82 | 2025 | Phasix Mesh |
| Misonix INC | $16.04 | 2020 | |
| Smith+Nephew, INC. | $14.53 | 2020 | |
| Olympus America INC. | $14.03 | 2024 | Endoclot Phs |
| Romark Laboratories, Lc | $7.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.